Editorial Board

Advances in Pharmacology & Clinical Trials

Home APCT Editorial Board Esam Z Dajani

Share this profile

LinkedIn Twitter / X

✓ Link copied!

Esam Z Dajani

Esam Z Dajani

Editorial Board Member
Loyola University Chicago Member since 2018

Biography

Esam Z Dajani Ph.D., FACG is the founder and president of International Drug Development Consultants (IDDC) Corporation, a Contract Research Organization (CRO) which provides scientific consulting services to pharmaceutical companies, law firms and governmental agencies. The scope of the consulting service includes clinical pharmacology, toxicology, drug development and regulatory affairs. He has directed worldwide clinical research and development at major pharmaceutical companies. He led the research teams that discovered and developed misoprostol (Cytotec), an anti-ulcer drug. Since 1980, he held continuous academic appointments in pharmacology and in medicine. He is currently serving as Adjunct Professor of Medicine at Loyola University-Chicago. He taught pharmacology and toxicology to medical, dental and pharmacy students.

Research Interests

Clinical Pharmacology Gastrointestinal Pharmacology Central Nervous System Pharmacology Prostaglandins Non-Steroidal Anti-Inflammatory Drugs (Nsaids) Growth Hormones (Eg: Epidermal Growth Factor) Cannabinoids and Narcotic Analgesics

Other Editorial Board Members

Submit Manuscript

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?